Header Logo

Connection

Trudy Morrison to Animals

Back to Details
This is a "connection" page, showing publications Trudy Morrison has written about Animals.
Trudy Morrison
Connection Strength
1.115
Animals
  1. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. 2023 05 31; 15(6).
    View in: PubMed
    Score: 0.058
  2. McGinnes Cullen L, Luo B, Wen Z, Zhang L, Durr E, Morrison TG. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. J Virol. 2023 01 31; 97(1):e0190022.
    View in: PubMed
    Score: 0.057
  3. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Chinmoun Z, Boukhvalova MS, Morrison TG. Correlative outcomes of maternal immunization against RSV in cotton rats. Hum Vaccin Immunother. 2022 12 30; 18(7):2148499.
    View in: PubMed
    Score: 0.056
  4. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats. PLoS Pathog. 2021 12; 17(12):e1009856.
    View in: PubMed
    Score: 0.053
  5. Blanco JCG, Fernando LR, Zhang W, Kamali A, Boukhvalova MS, McGinnes-Cullen L, Morrison TG. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus. J Virol. 2019 12 01; 93(23).
    View in: PubMed
    Score: 0.046
  6. McGinnes Cullen L, Schmidt MR, Morrison TG. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles. J Virol. 2019 05 01; 93(9).
    View in: PubMed
    Score: 0.044
  7. Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. Nat Commun. 2018 05 15; 9(1):1904.
    View in: PubMed
    Score: 0.041
  8. Cullen LM, Schmidt MR, Morrison TG. The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. Hum Vaccin Immunother. 2017 12 02; 13(12):2814-2823.
    View in: PubMed
    Score: 0.038
  9. Cullen LM, Blanco JC, Morrison TG. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J Transl Med. 2015 Nov 05; 13:350.
    View in: PubMed
    Score: 0.034
  10. McGinnes Cullen L, Schmidt MR, Kenward SA, Woodland RT, Morrison TG. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein. J Virol. 2015 Jul; 89(13):6835-47.
    View in: PubMed
    Score: 0.033
  11. Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. J Virol. 2014 Sep 01; 88(17):10165-76.
    View in: PubMed
    Score: 0.031
  12. Morrison TG. Meeting report VLPNPV: Session 3: Immune responses. Hum Vaccin Immunother. 2014; 10(10):3064-7.
    View in: PubMed
    Score: 0.030
  13. Morrison TG, Walsh EE. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:285-306.
    View in: PubMed
    Score: 0.028
  14. Schmidt MR, McGinnes LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol. 2012 Nov; 86(21):11654-62.
    View in: PubMed
    Score: 0.028
  15. Gravel KA, McGinnes LW, Reitter J, Morrison TG. The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein. J Virol. 2011 Apr; 85(7):3486-97.
    View in: PubMed
    Score: 0.025
  16. McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan; 85(1):366-77.
    View in: PubMed
    Score: 0.024
  17. McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG. Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol. 2010 May; 84(9):4513-23.
    View in: PubMed
    Score: 0.023
  18. Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan; 84(2):1110-23.
    View in: PubMed
    Score: 0.023
  19. Jain S, McGinnes LW, Morrison TG. Role of thiol/disulfide exchange in newcastle disease virus entry. J Virol. 2009 Jan; 83(1):241-9.
    View in: PubMed
    Score: 0.021
  20. Jain S, McGinnes LW, Morrison TG. Overexpression of thiol/disulfide isomerases enhances membrane fusion directed by the Newcastle disease virus fusion protein. J Virol. 2008 Dec; 82(24):12039-48.
    View in: PubMed
    Score: 0.021
  21. Jain S, McGinnes LW, Morrison TG. Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein. J Virol. 2007 Mar; 81(5):2328-39.
    View in: PubMed
    Score: 0.019
  22. Laliberte JP, McGinnes LW, Peeples ME, Morrison TG. Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J Virol. 2006 Nov; 80(21):10652-62.
    View in: PubMed
    Score: 0.018
  23. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol. 2006 Nov; 80(22):11062-73.
    View in: PubMed
    Score: 0.018
  24. McGinnes LW, Pantua H, Reitter J, Morrison TG. Newcastle disease virus: propagation, quantification, and storage. Curr Protoc Microbiol. 2006 Jun; Chapter 15:15F.2.1-15F.2.18.
    View in: PubMed
    Score: 0.018
  25. McGinnes LW, Morrison TG. Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes. J Virol. 2006 Mar; 80(6):2894-903.
    View in: PubMed
    Score: 0.018
  26. Pantua H, McGinnes LW, Leszyk J, Morrison TG. Characterization of an alternate form of Newcastle disease virus fusion protein. J Virol. 2005 Sep; 79(18):11660-70.
    View in: PubMed
    Score: 0.017
  27. Matsuda K, Harrison M, Wettstein E, Pederson J, Pullano AA, Bolkhovitinov L, Kim B, Steinberg I, Griesman T, Stuccio S, Rogan D, Patamawenu A, Shofner T, Wright NE, Webber JD, Van't Veer F, Roenicke R, Koory E, Roeder PM, Ober E, Leach B, Tsybovsky Y, Stephens T, Del Moral-Sanchez I, Bontjer I, McGinnes-Cullen LW, Chu E, Liang J, Torres JL, Lin RN, Tran AS, Dziubla G, Serebryannyy L, Narpala S, Lin B, Castro M, Ozorowski G, Ward AB, Sanders RW, Kwong PD, Guenaga J, Wyatt R, Morrison T, Connors M. Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response. Nat Commun. 2025 Jun 03; 16(1):5162.
    View in: PubMed
    Score: 0.017
  28. Dolganiuc V, McGinnes L, Luna EJ, Morrison TG. Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J Virol. 2003 Dec; 77(24):12968-79.
    View in: PubMed
    Score: 0.015
  29. Gravel KA, Morrison TG. Interacting domains of the HN and F proteins of newcastle disease virus. J Virol. 2003 Oct; 77(20):11040-9.
    View in: PubMed
    Score: 0.015
  30. McGinnes LW, Sergel T, Chen H, Hamo L, Schwertz S, Li D, Morrison TG. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein. Virology. 2001 Oct 25; 289(2):343-52.
    View in: PubMed
    Score: 0.013
  31. Sergel TA, McGinnes LW, Morrison TG. Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein. J Virol. 2001 Sep; 75(17):7934-43.
    View in: PubMed
    Score: 0.013
  32. Morrison TG. The three faces of paramyxovirus attachment proteins. Trends Microbiol. 2001 Mar; 9(3):103-5.
    View in: PubMed
    Score: 0.012
  33. Sergel TA, McGinnes LW, Morrison TG. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J Virol. 2000 Jun; 74(11):5101-7.
    View in: PubMed
    Score: 0.012
  34. Young JK, Li D, Abramowitz MC, Morrison TG. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. J Virol. 1999 Jul; 73(7):5945-56.
    View in: PubMed
    Score: 0.011
  35. Stone-Hulslander J, Morrison TG. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol. 1999 May; 73(5):3630-7.
    View in: PubMed
    Score: 0.011
  36. Blanco JCG, Boukhvalova MS, Morrison TG, Vogel SN. A multifaceted approach to RSV vaccination. Hum Vaccin Immunother. 2018 07 03; 14(7):1734-1745.
    View in: PubMed
    Score: 0.010
  37. McGinnes LW, Morrison TG. Role of carbohydrate processing and calnexin binding in the folding and activity of the HN protein of Newcastle disease virus. Virus Res. 1998 Feb; 53(2):175-85.
    View in: PubMed
    Score: 0.010
  38. Young JK, Hicks RP, Wright GE, Morrison TG. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology. 1997 Nov 24; 238(2):291-304.
    View in: PubMed
    Score: 0.010
  39. Stone-Hulslander J, Morrison TG. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol. 1997 Sep; 71(9):6287-95.
    View in: PubMed
    Score: 0.010
  40. McGinnes LW, Morrison TG. Disulfide bond formation is a determinant of glycosylation site usage in the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Virol. 1997 Apr; 71(4):3083-9.
    View in: PubMed
    Score: 0.009
  41. McGinnes LW, Morrison TG. Role of cotranslational disulfide bond formation in the folding of the hemagglutinin-neuraminidase protein of Newcastle disease virus. Virology. 1996 Oct 15; 224(2):465-76.
    View in: PubMed
    Score: 0.009
  42. McGinnes LW, Morrison TG. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus. Virology. 1995 Oct 01; 212(2):398-410.
    View in: PubMed
    Score: 0.009
  43. Reitter JN, Sergel T, Morrison TG. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol. 1995 Oct; 69(10):5995-6004.
    View in: PubMed
    Score: 0.009
  44. Sergel T, Morrison TG. Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology. 1995 Jul 10; 210(2):264-72.
    View in: PubMed
    Score: 0.008
  45. Ogembo JG, Muraswki MR, McGinnes LW, Parcharidou A, Sutiwisesak R, Tison T, Avendano J, Agnani D, Finberg RW, Morrison TG, Fingeroth JD. A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. J Transl Med. 2015 Feb 06; 13:50.
    View in: PubMed
    Score: 0.008
  46. McGinnes LW, Morrison TG. Modulation of the activities of HN protein of Newcastle disease virus by nonconserved cysteine residues. Virus Res. 1994 Dec; 34(3):305-16.
    View in: PubMed
    Score: 0.008
  47. McGinnes LW, Morrison TG. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. Virology. 1994 May 01; 200(2):470-83.
    View in: PubMed
    Score: 0.008
  48. McGinnes LW, Morrison TG. Conformationally sensitive antigenic determinants on the HN glycoprotein of Newcastle disease virus form with different kinetics. Virology. 1994 Mar; 199(2):255-64.
    View in: PubMed
    Score: 0.008
  49. Sergel T, McGinnes LW, Morrison TG. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology. 1993 Oct; 196(2):831-4.
    View in: PubMed
    Score: 0.007
  50. Sergel T, McGinnes LW, Peeples ME, Morrison TG. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 1993 Apr; 193(2):717-26.
    View in: PubMed
    Score: 0.007
  51. Battisti AJ, Meng G, Winkler DC, McGinnes LW, Plevka P, Steven AC, Morrison TG, Rossmann MG. Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):13996-4000.
    View in: PubMed
    Score: 0.007
  52. Morrison TG, McQuain C, O'Connell KF, McGinnes LW. Mature, cell-associated HN protein of Newcastle disease virus exists in two forms differentiated by posttranslational modifications. Virus Res. 1990 Feb; 15(2):113-33.
    View in: PubMed
    Score: 0.006
  53. Morrison TG, McGinnes LW. Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection. Virology. 1989 Jul; 171(1):10-7.
    View in: PubMed
    Score: 0.006
  54. Morrison TG, Peeples ME, McGinnes LW. Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption. Proc Natl Acad Sci U S A. 1987 Feb; 84(4):1020-4.
    View in: PubMed
    Score: 0.005
  55. Morrison TG, McGinnes LJ. Cytochalasin D accelerates the release of Newcastle disease virus from infected cells. Virus Res. 1985 Dec; 4(1):93-106.
    View in: PubMed
    Score: 0.004
  56. Morrison TG, Ward LJ. Intracellular processing of the vesicular stomatitis virus glycoprotein and the Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virus Res. 1984; 1(3):225-39.
    View in: PubMed
    Score: 0.004
  57. Chatis PA, Morrison TG. Characterization of the soluble glycoprotein released from vesicular stomatitis virus-infected cells. J Virol. 1983 Jan; 45(1):80-90.
    View in: PubMed
    Score: 0.004
  58. Chatis PA, Morrison TG. Fatty acid modification of Newcastle disease virus glycoproteins. J Virol. 1982 Jul; 43(1):342-7.
    View in: PubMed
    Score: 0.003
  59. Morrison TG, Simpson D. Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation. J Virol. 1980 Oct; 36(1):171-80.
    View in: PubMed
    Score: 0.003
  60. Morrison TG, Lodish HF. Translation of bacteriophage Q RNA by cytoplasmic extracts of mammalian cells. Proc Natl Acad Sci U S A. 1973 Feb; 70(2):315-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.